STOCK TITAN

Mohammed Qatanani (NASDAQ: SRRK) files Form 144 to sell 23,408 shares via option exercise

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Mohammed Qatanani filed a Form 144 notice to sell 23,408 shares of Common Stock on 04/06/2026 via a stock option exercise for cash. The filing lists three prior sales in the past three months: 13,112 shares on 01/14/2026, 14,898 shares on 01/22/2026, and 8,484 shares on 02/23/2026.

Positive

  • None.

Negative

  • None.
Noticed sale 23,408 shares Securities to be sold on 04/06/2026 via stock option exercise
Prior sale 1 13,112 shares Sale on 01/14/2026 (past 3 months section)
Prior sale 2 14,898 shares Sale on 01/22/2026 (past 3 months section)
Prior sale 3 8,484 shares Sale on 02/23/2026 (past 3 months section)
Post-transaction figure (example) 592,611 Figure listed adjacent to 01/14/2026 sale (interpreted from filing lines)
Post-transaction figure (example) 695,938 Figure listed adjacent to 01/22/2026 sale (interpreted from filing lines)
Post-transaction figure (example) 399,350 Figure listed adjacent to 02/23/2026 sale (interpreted from filing lines)
Form 144 regulatory
"Filed notice to sell 23,408 shares on 04/06/2026"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Stock Option Exercise financial
"Securities To Be Sold | Stock Option Exercise | Issuer"
A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.
Issuer financial
"Securities To Be Sold | Stock Option Exercise | Issuer"
Cash financial
"Securities To Be Sold | 04/06/2026 | Cash"

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does Mohammed Qatanani's Form 144 for SRRK report?

It reports a planned sale of 23,408 shares on 04/06/2026. The sale is described as a stock option exercise for cash. The filing also discloses three prior sales totaling 36,494 shares earlier in 2026.

How many shares were sold by the reporting person in the prior three months for SRRK?

Three sales totaling 36,494 shares were reported. The entries are 13,112 shares (01/14/2026), 14,898 shares (01/22/2026), and 8,484 shares (02/23/2026), with post-transaction figures listed alongside each sale.

What method is being used to sell the SRRK shares in the Form 144?

The Form 144 lists a stock option exercise followed by a cash sale. The securities to be sold on 04/06/2026 are identified as Common Stock resulting from a stock option exercise.

Does the Form 144 indicate who will receive the sale proceeds for SRRK?

The filing states the sale is for cash following an option exercise. It identifies the transaction as an issuer-related stock option exercise but does not specify allocation of proceeds beyond the cash treatment.